Phreesia, Inc. (PHR)
Phreesia, Inc. offers a SaaS-based platform for healthcare organizations, streamlining patient intake and payment processes. Their integrated solutions aim to improve efficiency and patient experience in the healthcare sector.
Company Overview
Phreesia is revolutionizing patient intake with its SaaS platform, offering streamlined workflows and integrated payment solutions for healthcare providers. With a focus on enhancing patient experience and operational efficiency, Phreesia is poised to capitalize on the growing demand for digital health solutions, making it an attractive investment.
Investment Thesis
Phreesia presents a compelling investment opportunity due to its strong market position and growth potential within the healthcare technology sector. The company's integrated SaaS platform addresses critical needs in patient intake and payment processing, driving efficiency and improving patient experience. With a gross margin of 68.2%, Phreesia demonstrates a solid foundation for profitability as it scales its operations. Key value drivers include the increasing adoption of digital health solutions, expansion into new specialties and healthcare settings, and strategic partnerships with pharmaceutical and medical device companies. The company's focus on innovation and its ability to adapt to evolving healthcare needs position it for sustained growth. As healthcare providers continue to prioritize efficiency and patient engagement, Phreesia is well-positioned to capitalize on these trends.
Key Highlights
- Phreesia's SaaS-based platform streamlines patient intake and payment processes, enhancing efficiency for healthcare providers.
- The company's gross margin of 68.2% indicates strong profitability potential as it scales its operations.
- Phreesia serves a diverse range of clients, including single-specialty practices, multi-specialty groups, and health systems.
- The Phreesia Platform offers a comprehensive suite of solutions, including registration, revenue cycle management, and clinical support.
- Phreesia's platform supports various modalities, including mobile devices, tablets, and on-site kiosks, providing flexibility for patients and providers.
Competitors
Strengths
- Integrated SaaS platform with comprehensive functionality.
- Strong market position in patient intake and payment solutions.
- Diverse customer base across various healthcare segments.
- High gross margin indicating profitability potential.
Weaknesses
- Negative profit margin (-1.2%) indicates current unprofitability.
- High P/E ratio (-134.98) suggests overvaluation or lack of earnings.
- Reliance on the healthcare industry, making it susceptible to regulatory changes.
- Limited geographic presence outside of the United States and Canada.
Catalysts
- Ongoing: Continued adoption of digital health solutions by healthcare providers.
- Upcoming: Expansion into new medical specialties and healthcare settings.
- Ongoing: Strategic partnerships with pharmaceutical and medical device companies.
- Ongoing: Increased utilization of telehealth services.
Risks
- Potential: Competition from established players and emerging startups in the healthcare technology market.
- Potential: Cybersecurity risks and data privacy breaches compromising patient information.
- Potential: Changes in healthcare regulations and reimbursement policies impacting revenue.
- Ongoing: Negative profit margin and high P/E ratio indicating financial instability.
- Potential: Economic downturns reducing healthcare spending and impacting customer demand.
Growth Opportunities
- Expansion into New Specialties: Phreesia has the opportunity to expand its platform to support additional medical specialties beyond the current 25. This would involve tailoring the platform's clinical support solution to meet the specific needs of each specialty, including the collection of relevant patient-reported outcome (PRO) data. The addressable market for this expansion is significant, as it encompasses a wide range of medical fields seeking to improve patient care and streamline workflows. This initiative could drive substantial revenue growth and strengthen Phreesia's position as a leading provider of healthcare technology solutions.
- Strategic Partnerships with Pharmaceutical Companies: Phreesia can leverage its platform to forge strategic partnerships with pharmaceutical companies, offering targeted marketing and patient engagement solutions. By delivering clinically relevant content to patients through the Phreesia Platform, pharmaceutical companies can improve medication adherence and patient outcomes. This represents a significant revenue opportunity for Phreesia, as pharmaceutical companies are increasingly seeking innovative ways to connect with patients and promote their products. These partnerships could also enhance Phreesia's value proposition to healthcare providers by providing access to valuable resources and support.
- Increased Adoption of Telehealth Solutions: The growing adoption of telehealth presents a significant growth opportunity for Phreesia. The company's platform already supports telehealth visits through features such as contactless check-in and remote intake information collection. As telehealth becomes more prevalent, Phreesia can further enhance its platform to meet the evolving needs of virtual care providers. This includes integrating with telehealth platforms, developing new features for remote patient monitoring, and providing tools for virtual patient engagement. By capitalizing on the telehealth trend, Phreesia can expand its market reach and solidify its position as a leader in healthcare technology.
- Penetration of the Canadian Market: Phreesia currently operates in both the United States and Canada, but there is significant potential to further penetrate the Canadian market. By tailoring its platform to meet the specific needs of Canadian healthcare providers and patients, Phreesia can capture a larger share of this market. This includes addressing regulatory requirements, integrating with Canadian healthcare systems, and providing localized customer support. The Canadian market represents a valuable growth opportunity for Phreesia, as it offers a stable and well-developed healthcare system with a growing demand for digital health solutions.
- Development of Advanced Analytics and Reporting Tools: Phreesia can enhance its platform by developing advanced analytics and reporting tools that provide healthcare providers with valuable insights into patient data and operational performance. These tools could help providers identify trends, optimize workflows, and improve patient outcomes. By offering these capabilities, Phreesia can increase the value of its platform and attract new customers. The market for healthcare analytics is growing rapidly, as providers seek to leverage data to improve care delivery and reduce costs. This represents a significant growth opportunity for Phreesia, as it can position itself as a leader in healthcare analytics and data-driven decision-making.
Opportunities
- Expansion into new medical specialties and healthcare settings.
- Strategic partnerships with pharmaceutical and medical device companies.
- Increased adoption of telehealth solutions.
- Development of advanced analytics and reporting tools.
Threats
- Competition from established players and emerging startups.
- Cybersecurity risks and data privacy concerns.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting healthcare spending.
Competitive Advantages
- Integrated platform offering a comprehensive suite of solutions.
- Extensive network of healthcare providers and patients.
- Proprietary technology and data analytics capabilities.
- Strong brand reputation and customer loyalty.
- High switching costs due to integration with existing healthcare workflows.
About
Founded in 2005 and headquartered in Raleigh, North Carolina, Phreesia, Inc. has emerged as a leading provider of integrated SaaS-based software and payment solutions for the healthcare industry in the United States and Canada. The company's core offering, the Phreesia Platform, delivers a comprehensive suite of tools designed to modernize and optimize the patient intake process. This platform encompasses various modalities, including Phreesia Mobile for patient mobile devices, Phreesia Dashboard for healthcare client management, PhreesiaPads for self-service intake, and Arrivals Kiosks for on-site check-in. Phreesia's solutions extend beyond basic intake, offering features such as automated patient self-registration, insurance verification, point-of-sale payment processing, and cost estimation tools. The platform also facilitates appointment scheduling, reminders, referral tracking, and the delivery of targeted marketing content from life sciences companies. Furthermore, Phreesia provides clinical support by collecting patient-reported outcome (PRO) data across approximately 25 specialties, enabling healthcare providers to communicate with patients through surveys, announcements, and health campaigns. The company also offers COVID-19 support modules for vaccine management and risk factor screening. Phreesia serves a diverse clientele, including single-specialty practices, multi-specialty groups, health systems, and pharmaceutical, medical device, and biotechnology companies.
What They Do
- Provides a SaaS-based platform for healthcare organizations.
- Streamlines patient intake and registration processes.
- Offers integrated payment solutions for patient payments.
- Facilitates appointment scheduling and reminders.
- Delivers targeted marketing content to patients from life sciences companies.
- Collects clinical intake and patient-reported outcome (PRO) data.
- Enables communication with patients through surveys, announcements, and health campaigns.
Business Model
- Subscription fees for access to the Phreesia Platform.
- Transaction fees for payment processing.
- Revenue from life sciences companies for targeted marketing campaigns.
- Fees for additional modules and services, such as advanced analytics and reporting.
Industry Context
Phreesia operates within the rapidly evolving healthcare information services industry, which is experiencing significant growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare operations. The market is characterized by a mix of established players and emerging startups, all vying to provide innovative solutions for healthcare providers. Competitors include companies like BLFS (BioLife Solutions), ESTA (Establishment Labs Holdings Inc), GDRX (GoodRx Holdings, Inc.), KMTS (KMT Medical Technology), and NEOG (Neogen Corporation). Phreesia differentiates itself through its integrated platform approach, offering a comprehensive suite of solutions that address multiple aspects of the patient intake and payment process.
Key Customers
- Single-specialty practices.
- Multi-specialty groups.
- Health systems.
- Pharmaceutical companies.
- Medical device companies.
- Biotechnology companies.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $120M | $4M | $0.00 |
| Q3 2025 | $117M | $654,000 | $0.00 |
| Q2 2025 | $116M | -$4M | $0.00 |
| Q1 2025 | $110M | -$6M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
Phreesia, Inc. (PHR) stock price: $12.44 (+0.00, +0.00%)
Why Bull
- •Recent insider buying suggests confidence in PHR's future, indicating that those closest to the company believe in its potential.
- •Community sentiment has shifted positively as discussions around PHR's innovative product pipeline gain traction, highlighting strong interest.
- •Analysts have noted improved operational efficiencies, which could lead to better margins and profitability in the upcoming quarters.
- •The market perception of PHR has been bolstered by favorable news coverage, enhancing its visibility and attracting potential investors.
Why Bear
- •Some community members express concerns over PHR's competitive positioning, fearing it may struggle against larger rivals in the sector.
- •Recent social sentiment has shown skepticism regarding the sustainability of PHR's growth, with questions raised about long-term viability.
- •Insider selling activity has raised red flags for some investors, suggesting potential lack of confidence among certain executives.
- •Market developments indicate a cautious approach from institutional investors, which could signal a bearish outlook on PHR's future performance.
Latest News
-
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga · Dec 9, 2025
-
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga · Dec 8, 2025
-
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga · Sep 5, 2025
Technical Analysis
Rationale
AI-generated technical analysis for PHR including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Phreesia, Inc. (PHR) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for PHR.
Make a Prediction
Set your price target for Phreesia, Inc. (PHR), choose a timeframe, and track your prediction accuracy.
Current price: $12.44
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PHR.
Price Targets
Wall Street price target analysis for PHR.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 17.8% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 10/100
Gross margin of 68.2% shows excellent pricing power and a strong competitive moat.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 10/100
Insiders bought +$2.15M net in recent filings, a strong confidence signal from those who know the company best.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates PHR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Frequently Asked Questions
What does Phreesia, Inc. do?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry. The company's Phreesia Platform offers a suite of solutions designed to manage the patient intake process, including self-registration, insurance verification, payment processing, and clinical data collection. By streamlining these processes, Phreesia aims to improve efficiency for healthcare providers and enhance the patient experience. The platform is deployed in various modalities, such as mobile devices, tablets, and on-site kiosks, catering to diverse healthcare settings and patient preferences. Phreesia serves a wide range of clients, including single-specialty practices, multi-specialty groups, and health systems.
Is PHR stock a good buy?
PHR stock presents a mixed investment picture. The company's strong market position and innovative platform are attractive, but its current financial metrics raise concerns. While Phreesia boasts a high gross margin of 68.2%, its negative profit margin of -1.2% and high P/E ratio of -134.98 suggest that the company is not yet profitable. Investors should carefully consider the company's growth potential, competitive landscape, and financial stability before making an investment decision. The increasing adoption of digital health solutions and Phreesia's expansion into new markets could drive future growth, but potential risks such as competition and regulatory changes should also be taken into account.
What are the main risks for PHR?
Phreesia faces several key risks that investors should be aware of. The company operates in a competitive market, with established players and emerging startups vying for market share. Cybersecurity risks and data privacy concerns are also significant, as a breach could damage the company's reputation and result in financial losses. Changes in healthcare regulations and reimbursement policies could negatively impact Phreesia's revenue. Additionally, the company's current financial metrics, including a negative profit margin and high P/E ratio, indicate potential financial instability. Economic downturns could also reduce healthcare spending and impact customer demand for Phreesia's solutions.
Is PHR a good stock to buy?
Whether PHR is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the PHR MoonshotScore?
The MoonshotScore for PHR is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is PHR data updated?
PHR stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to PHR is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for PHR?
Growth catalysts for Phreesia, Inc. (PHR) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Phreesia, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are PHR's main competitors?
Phreesia, Inc. (PHR) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether PHR has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about PHR?
Wall Street analyst coverage for PHR includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is PHR's market cap?
Market capitalization (market cap) for PHR is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows PHR's current market cap alongside enterprise value and other valuation metrics.
How has PHR stock performed recently?
PHR's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing PHR's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in PHR?
Key risk categories for PHR include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures PHR's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling PHR?
Insider trading activity for PHR tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is PHR a good stock for beginners?
Phreesia, Inc. (PHR) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is PHR for first-time investors?
Every stock carries risk, including Phreesia, Inc. (PHR). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like PHR.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Stock data pending update. Financial data is based on the most recent available information.
- The competitive landscape is subject to change as new players enter the market and existing players evolve their strategies.